Yeast as a model organism for the pharmaceutical and nutraceutical industries

References

[1]  http://www.yeastgenome.org/a-nobel-prize-for-work-in-yeast-again

[2]  Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245–246.
| A novel genetic system to detect protein-protein interactions.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL1MXltlShsL8%3D&md5=52c6d68b44ad71257bddbc15e9ba413eCAS |

[3]  Vidal, M. et al. (1996) Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions. Proc. Natl. Acad. Sci. USA 93, 10315–10320.
| Reverse two-hybrid and one-hybrid systems to detect dissociation of protein-protein and DNA-protein interactions.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK28XlslGkur8%3D&md5=056c4add18982ddd8e00d4f631f3fd78CAS |

[4]  Wikhe, K. et al. (2007) Biological consequences of statins in Candida species and possible implications for human health. Biochem. Soc. Trans. 35, 1529–1532.
| Biological consequences of statins in Candida species and possible implications for human health.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2sXhtlGmtLrK&md5=82af3afe2ebe717e5e65a50f1811722fCAS |

[5]  Bharadwaj, P.R. et al. (2012) Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Abeta42 levels in yeast. J. Alzheimers Dis. 32, 949–967.
| 1:CAS:528:DC%2BC38Xhs1Kru7bL&md5=8f7e8b23b0ccdf142cb650733dc3a483CAS |

[6]  Macreadie, I.G. et al. (2016) Finding chemopreventatives to reduce amyloid beta in yeast. Neural Regen. Res. 11, 244–245.
| Finding chemopreventatives to reduce amyloid beta in yeast.Crossref | GoogleScholarGoogle Scholar |

[7]  Porzoor, A. and Macreadie, I. (2016) Yeast as a model for studies on Aβ aggregation toxicity in Alzheimer’s disease, autophagic responses, and drug screening. Methods Mol. Biol. 1303, 217–226.
| Yeast as a model for studies on Aβ aggregation toxicity in Alzheimer’s disease, autophagic responses, and drug screening.Crossref | GoogleScholarGoogle Scholar |

[8]  Outeiro, T.F. and Lindquist, S. (2003) Yeast cells provide insight into alpha-synuclein biology and pathobiology. Science 302, 1772–1775.
| Yeast cells provide insight into alpha-synuclein biology and pathobiology.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD3sXpsVWns74%3D&md5=32924f8f421b55b554fb7fa973bcc553CAS |

[9]  Wickner, R.B. (1994) [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 264, 566–569.
| [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK2cXivFeksLs%3D&md5=2b8473f2bd0148392ef361a4dfbee7faCAS |

[10]  Nurse, P. and Thuriaux, P. (1980) Regulatory genes controlling mitosis in the fission yeast Schizosaccharomyces pombe. Genetics 96, 627–637.
| 1:STN:280:DyaL3M3mtFyrsg%3D%3D&md5=ee5ea3e9c35dc67cdd1f829bda625155CAS |

[11]  Patel, O. et al. (2004) Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast. FEMS Microbiol. Lett. 236, 301–305.
| Over-production of dihydrofolate reductase leads to sulfa-dihydropteroate resistance in yeast.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD2cXls1ajtLk%3D&md5=0bc8bace08c993e2426b974ddd3c33deCAS |

[12]  Sibley, C.H. and Macreadie, I. (2001) Novel approaches to tackling malarial drug resistance using yeast. IUBMB Life 52, 285–289.
| Novel approaches to tackling malarial drug resistance using yeast.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BD38XitFCksrg%3D&md5=8a5ba008c2feef5fae07b5e3b3caa818CAS |

[13]  Sankovich, S.E. et al. (1998) Design and assay of inhibitors of HIV-1 Vpr cell killing and growth arrest activities using microbial assay systems. J. Biomol. Screen. 3, 299–304.
| Design and assay of inhibitors of HIV-1 Vpr cell killing and growth arrest activities using microbial assay systems.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaK1MXmsVahsA%3D%3D&md5=d1451b15a3edd930ec76f42699dfb384CAS |

[14]  Macreadie, I.G. et al. (2010) Inhibition of respiratory growth and survival in yeast by dopamine and counteraction with ascorbate or glutathione. J. Biomol. Screen. 15, 297–301.
| Inhibition of respiratory growth and survival in yeast by dopamine and counteraction with ascorbate or glutathione.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXksFWjsrc%3D&md5=8e33c14cf62c7c26cc03bce357e793b1CAS |

[15]  Phillips, J.A. and Macreadie, I.G. (2017) Inhibition of respiration in yeast by 2-phenylethylamine. Curr. Bioact. Compd. 13, .

[16]  Longo, V.D. et al. (2010) Endosomal protein sorting and autophagy genes contribute to the regulation of yeast life span. Autophagy 6, 1227–1228.
| Endosomal protein sorting and autophagy genes contribute to the regulation of yeast life span.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXhs1WltrbL&md5=6a00b46ca3a97d12d91a789abf5d1d6eCAS |

[17]  Lasserre, J.P. et al. (2015) Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Dis. Model. Mech. 8, 509–526.
| Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC2MXhsVCmtbrK&md5=dc64e70e9ff38675cbf84f0141172721CAS |

[18]  Laurent, J.M. et al. (2016) Efforts to make and apply humanized yeast. Brief. Funct. Genomics 15, 155–163.
| Efforts to make and apply humanized yeast.Crossref | GoogleScholarGoogle Scholar |

[19]  Verbandt, S. et al. (2017) Yeast as a model for the identification of novel survival-promoting compounds applicable to treat degenerative diseases. Mech. Ageing Dev. 161, 306–316.
| 1:CAS:528:DC%2BC28XhtVaht7bJ&md5=65bd7e8e1efd470ac21ad3045d8e2313CAS |

[20]  Banerjee, D. et al. (1995) Molecular mechanisms of resistance to antifolates, a review. Acta Biochim. Pol. 42, 457–464.
| 1:CAS:528:DyaK28XitVymtbc%3D&md5=aa496b567d2a52d428c592736ee4bfdeCAS |